HRMY
Harmony BiosciencesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
HRMY vs peer average
68/100
HRMY vs. peer average (B vs. C)
Grade spread
B 3 · C 3 · D 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ANIP is the first available peer comparator.
ANI Pharmaceuticals is a somewhat closer commercial specialty-pharma comparator by size than large-cap biotech names, but its portfolio mix is broader and less tied to a single sleep-wake franchise, so read-through to HRMY is limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
HRMY
Harmony Biosciences
ANIP
ANI
Grade
B
C
Momentum
58
23
Value
71
68
Sentiment
34
61
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs ANIP
HRMY / ANIP
Grade Position
In line
HRMY vs. peer average (B vs. C)
68/100
Momentum
58
HRMYValue
71
HRMYSentiment
34
ANIPRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs HRMY
ANIP is the first peer returned for this comparison set.